{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:41:05Z","timestamp":1792798865539,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Brain bases and progression of methotrexate-associated neurotoxicity and cognitive disturbances remain unknown. We tested whether brain abnormalities worsen in proportion to intrathecal methotrexate(IT-MTX) doses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this prospective, longitudinal study, we recruited 19 patients with newly diagnosed acute lymphoblastic leukemia 4-to-20 years of age and 20 matched controls. We collected MRI and neuropsychological assessments at a pre-methotrexate baseline and at week 9, week 22, and year 1 during treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Patients had baseline abnormalities in cortical and subcortical gray matter(GM), white matter(WM) volumes and microstructure, regional cerebral blood flow, and neuronal density. Abnormalities of GM, blood flow, and metabolites worsened in direct proportions to IT-MTX doses. WM abnormalities persisted until week 22 but normalized by year 1. Brain injuries were localized to dorsal and ventral attentional and frontoparietal cognitive networks. Patients had cognitive deficits at baseline that persisted at 1-year follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Baseline abnormalities are likely a consequence of neuroinflammation and oxidative stress. Baseline abnormalities in WM microstructure and volumes, and blood flow persisted until week 22 but normalized by year 1, likely due to treatment and its effects on reducing inflammation. The cytotoxic effects of IT-MTX, however, likely contributed to continued, progressive cortical thinning and reductions in neuronal density, thereby contributing to enduring cognitive deficits.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Impact<\/jats:title>\n            <jats:p>\n              <jats:list list-type=\"bullet\">\n                <jats:list-item>\n                  <jats:p>Brain abnormalities at a pre-methotrexate baseline likely are due to acute illness. The cytotoxic effects of intrathecal MTX contribute to progressive cortical thinning, reductions in neuronal density, and enduring cognitive deficits.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>Baseline white matter abnormalities may have normalized via methotrexate treatment and decreasing neuroinflammation. Corticosteroid and leucovorin conferred neuroprotective effects.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>Our findings suggest that the administration of neuroprotective and anti-inflammatory agents should be considered even earlier than they are currently administered. The neuroprotective effects of leucovorin suggest that strategies may be developed that extend the duration of this intervention or adapt it for use in standard risk patients.<\/jats:p>\n                <\/jats:list-item>\n              <\/jats:list>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1038\/s41390-024-03351-9","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T18:02:58Z","timestamp":1719856978000},"page":"348-359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Progression of brain injuries associated with methotrexate chemotherapy in childhood acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"97","author":[{"given":"Ravi","family":"Bansal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Bhojwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernice F.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhant","family":"Sawardekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Wayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Ouassil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaitanya","family":"Gupte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Marcelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Gonzalez Anaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley S.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,1]]},"reference":[{"key":"3351_CR1","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1200\/JCO.2013.53.0808","volume":"32","author":"D Bhojwani","year":"2014","unstructured":"Bhojwani, D. et al. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J. Clin. Oncol. 32, 949\u2013959 (2014).","journal-title":"J. Clin. Oncol."},{"key":"3351_CR2","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1093\/brain\/awu230","volume":"137","author":"MN Edelmann","year":"2014","unstructured":"Edelmann, M. N. et al. Diffusion tensor imaging and neurocognition in survivors of childhood acute lymphoblastic leukaemia. Brain 137, 2973\u20132983 (2014).","journal-title":"Brain"},{"key":"3351_CR3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.tins.2018.05.001","volume":"41","author":"TS Horowitz","year":"2018","unstructured":"Horowitz, T. S., Suls, J. & Trevino, M. A call for a neuroscience approach to cancer-related cognitive impairment. Trends Neurosci. 41, 493\u2013496 (2018).","journal-title":"Trends Neurosci."},{"key":"3351_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00234-016-1777-8","volume":"59","author":"O Zajac-Spychala","year":"2017","unstructured":"Zajac-Spychala, O. et al. Long-term brain structural magnetic resonance imaging and cognitive functioning in children treated for acute lymphoblastic leukemia with high-dose methotrexate chemotherapy alone or combined with CNS radiotherapy at reduced total dose to 12 Gy. Neuroradiology 59, 147\u2013156 (2017).","journal-title":"Neuroradiology"},{"key":"3351_CR5","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1080\/10428194.2018.1434879","volume":"59","author":"O Zajac-Spychala","year":"2018","unstructured":"Zajac-Spychala, O. et al. Anti-leukemic treatment-induced neurotoxicity in long-term survivors of childhood acute lymphoblastic leukemia: impact of reduced central nervous system radiotherapy and intermediate- to high-dose methotrexate. Leuk. Lymphoma 59, 2342\u20132351 (2018).","journal-title":"Leuk. Lymphoma"},{"key":"3351_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1067\/mpd.2001.117066","volume":"139","author":"A Kingma","year":"2001","unstructured":"Kingma, A. et al. Slight cognitive impairment and magnetic resonance imaging abnormalities but normal school levels in children treated for acute lymphoblastic leukemia with chemotherapy only. J. Pediatr. 139, 413\u2013420 (2001).","journal-title":"J. Pediatr."},{"key":"3351_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.621","volume":"7","author":"E van der Plas","year":"2017","unstructured":"van der Plas, E. et al. Brain structure, working memory and response inhibition in childhood leukemia Survivors. Brain Behav. 7, e00621 (2017).","journal-title":"Brain Behav."},{"key":"3351_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/0284186X.2021.1987514","volume":"61","author":"D Svard","year":"2022","unstructured":"Svard, D. et al. Cognitive interference processing in adult survivors of childhood acute lymphoblastic leukemia using functional magnetic resonance imaging. Acta Oncol. 61, 333\u2013340 (2022).","journal-title":"Acta Oncol."},{"key":"3351_CR9","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.3174\/ajnr.A1733","volume":"30","author":"WE Reddick","year":"2009","unstructured":"Reddick, W. E., Glass, J. O., Johnson, D. P., Laningham, F. H. & Pui, C. H. Voxel-based analysis of T2 hyperintensities in white matter during treatment of childhood leukemia. AJNR Am. J. Neuroradiol. 30, 1947\u20131954 (2009).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"3351_CR10","first-page":"2371","volume":"26","author":"WE Reddick","year":"2005","unstructured":"Reddick, W. E. et al. A quantitative MR imaging assessment of leukoencephalopathy in children treated for acute lymphoblastic leukemia without irradiation. Am. J. Neuroradiol. 26, 2371\u20132377 (2005).","journal-title":"Am. J. Neuroradiol."},{"key":"3351_CR11","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1148\/rg.314105180","volume":"31","author":"E Vazquez","year":"2011","unstructured":"Vazquez, E. et al. Side effects of oncologic therapies in the pediatric central nervous system: update on neuroimaging findings. Radiographics 31, 1123\u20131139 (2011).","journal-title":"Radiographics"},{"key":"3351_CR12","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.2169\/internalmedicine.0855-22","volume":"62","author":"H Fujisawa","year":"2023","unstructured":"Fujisawa, H. et al. Methotrexate-induced subacute encephalopathy that showed no abnormalities on magnetic resonance imaging soon after symptom appearance. Intern Med 62, 2249\u20132252 (2023).","journal-title":"Intern Med"},{"key":"3351_CR13","first-page":"4868","volume":"28","author":"G McAlonan","year":"2010","unstructured":"McAlonan, G. White matter anisotropy in post-treatment childhood cancer survivors: preliminary evidence of association with neurocognitive function (Vol 24, Pg 884, 2006). J. Clin. Oncol. 28, 4868\u20134868 (2010).","journal-title":"J. Clin. Oncol."},{"key":"3351_CR14","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.ijrobp.2008.08.060","volume":"74","author":"EJ Aukema","year":"2009","unstructured":"Aukema, E. J. et al. White matter fractional anisotropy correlates with speed of processing and motor speed in young childhood cancer survivors. Int. J. Radiat. Oncol. Biol. Phys. 74, 837\u2013843 (2009).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"3351_CR15","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s11682-010-9104-1","volume":"4","author":"SR Kesler","year":"2010","unstructured":"Kesler, S. R., Tanaka, H. & Koovakkattu, D. Cognitive reserve and brain volumes in pediatric acute lymphoblastic leukemia. Brain Imaging Behav. 4, 256\u2013269 (2010).","journal-title":"Brain Imaging Behav."},{"key":"3351_CR16","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/pbc.24947","volume":"61","author":"WE Reddick","year":"2014","unstructured":"Reddick, W. E. et al. Prognostic factors that increase the risk for reduced white matter volumes and deficits in attention and learning for survivors of childhood cancers. Pediatr. Blood Cancer 61, 1074\u20131079 (2014).","journal-title":"Pediatr. Blood Cancer"},{"key":"3351_CR17","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1007\/s00330-023-09473-8","volume":"33","author":"LP Lin","year":"2023","unstructured":"Lin, L. P. et al. Glymphatic system dysfunction in pediatric acute lymphoblastic leukemia without clinically diagnosed central nervous system infiltration: a novel Dti-Alps method. Eur. Radio. 33, 3726\u20133734 (2023).","journal-title":"Eur. Radio."},{"key":"3351_CR18","doi-asserted-by":"publisher","first-page":"e78599","DOI":"10.1371\/journal.pone.0078599","volume":"8","author":"M Genschaft","year":"2013","unstructured":"Genschaft, M. et al. Impact of chemotherapy for childhood leukemia on brain morphology and function. PLoS One 8, e78599 (2013).","journal-title":"PLoS One"},{"key":"3351_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27968","volume":"67","author":"NS Phillips","year":"2020","unstructured":"Phillips, N. S. et al. Neuroanatomical abnormalities related to dexamethasone exposure in survivors of childhood acute lymphoblastic leukemia. Pediatr. Blood Cancer 67, e27968 (2020).","journal-title":"Pediatr. Blood Cancer"},{"key":"3351_CR20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s10549-010-1088-4","volume":"123","author":"BC McDonald","year":"2010","unstructured":"McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D. & Saykin, A. J. Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res Treat. 123, 819\u2013828 (2010).","journal-title":"Breast Cancer Res Treat."},{"key":"3351_CR21","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.bbi.2012.05.007","volume":"30","author":"BC McDonald","year":"2013","unstructured":"McDonald, B. C., Conroy, S. K., Smith, D. J., West, J. D. & Saykin, A. J. Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study. Brain Behav. Immun. 30, S117\u2013S125 (2013).","journal-title":"Brain Behav. Immun."},{"key":"3351_CR22","doi-asserted-by":"publisher","first-page":"pkab069","DOI":"10.1093\/jncics\/pkab069","volume":"5","author":"K Gandy","year":"2021","unstructured":"Gandy, K. et al. Structural and functional brain imaging in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy: a systematic review. JNCI Cancer Spectr. 5, pkab069 (2021).","journal-title":"JNCI Cancer Spectr."},{"key":"3351_CR23","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/1096-911X(20001101)35:5<456::AID-MPO3>3.0.CO;2-1","volume":"35","author":"E Paakko","year":"2000","unstructured":"Paakko, E. et al. White matter changes on mri during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings. Med Pediatr. Oncol. 35, 456\u2013461 (2000).","journal-title":"Med Pediatr. Oncol."},{"key":"3351_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1148\/radiology.180.1.2052695","volume":"180","author":"DA Wilson","year":"1991","unstructured":"Wilson, D. A. et al. Transient white matter changes on mr images in children undergoing chemotherapy for acute lymphocytic leukemia: correlation with neuropsychologic deficiencies. Radiology 180, 205\u2013209 (1991).","journal-title":"Radiology"},{"key":"3351_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/RLI.0000000000000715","volume":"56","author":"JR Pryweller","year":"2021","unstructured":"Pryweller, J. R. et al. Characterization of leukoencephalopathy and association with later neurocognitive performance in pediatric acute lymphoblastic leukemia. Invest Radio. 56, 117\u2013126 (2021).","journal-title":"Invest Radio."},{"key":"3351_CR26","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1148\/radiol.2293021550","volume":"229","author":"WC Chu","year":"2003","unstructured":"Chu, W. C. et al. White matter and cerebral metabolite changes in children undergoing treatment for acute lymphoblastic leukemia: longitudinal study with mr imaging and 1h MR spectroscopy. Radiology 229, 659\u2013669 (2003).","journal-title":"Radiology"},{"key":"3351_CR27","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s00247-020-04717-x","volume":"50","author":"N Ramli","year":"2020","unstructured":"Ramli, N. et al. Assessing changes in microstructural integrity of white matter tracts in children with leukaemia following exposure to chemotherapy. Pediatr. Radio. 50, 1277\u20131283 (2020).","journal-title":"Pediatr. Radio."},{"key":"3351_CR28","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.braindev.2017.04.014","volume":"39","author":"Z Hu","year":"2017","unstructured":"Hu, Z. et al. Altered brain function in new onset childhood acute lymphoblastic leukemia before chemotherapy: a resting-state FMRI study. Brain Dev. 39, 743\u2013750 (2017).","journal-title":"Brain Dev."},{"key":"3351_CR29","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.21037\/qims-21-748","volume":"12","author":"K Wei","year":"2022","unstructured":"Wei, K. et al. An observational mri study of methotrexate-treated children with acute lymphoblastic leukemia in remission and subtle cognitive decline. Quant. Imaging Med Surg. 12, 2474\u20132486 (2022).","journal-title":"Quant. Imaging Med Surg."},{"key":"3351_CR30","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/pbc.24420","volume":"60","author":"SP Hunger","year":"2013","unstructured":"Hunger, S. P. et al. Children\u2019s oncology group\u2019s 2013 blueprint for research: acute lymphoblastic leukemia. Pediatr. Blood Cancer 60, 957\u2013963 (2013).","journal-title":"Pediatr. Blood Cancer"},{"key":"3351_CR31","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/ijc.29708","volume":"138","author":"HR Mitchell","year":"2016","unstructured":"Mitchell, H. R. et al. Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: results of children\u2019s oncology group study Aall0331. Int J. Cancer 138, 332\u2013339 (2016).","journal-title":"Int J. Cancer"},{"key":"3351_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","volume":"14","author":"M Smith","year":"1996","unstructured":"Smith, M. et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J. Clin. Oncol. 14, 18\u201324 (1996).","journal-title":"J. Clin. Oncol."},{"key":"3351_CR33","doi-asserted-by":"crossref","unstructured":"Wechsler, D. Wechsler Adult Intelligence Scale-Fourth Edition (Wais-Iv) (Pearson, Bloomington, MN, 2008).","DOI":"10.1037\/t15169-000"},{"key":"3351_CR34","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","volume":"36","author":"J Kaufman","year":"1997","unstructured":"Kaufman, J. et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (k-sads-pl): initial reliability and validity data. J. Am. Acad. Child Adolesc. Psychiatry 36, 980\u2013988 (1997).","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"3351_CR35","first-page":"979","volume":"21","author":"EO Poznanski","year":"1985","unstructured":"Poznanski, E. O., Freeman, L. N., Mokros, H. B. & Childrens Depression Rating-Scale, - Revised (September 1984). Psychopharmacol. Bull. 21, 979\u2013989 (1985).","journal-title":"Psychopharmacol. Bull."},{"key":"3351_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1207\/s15374424jccp2003_3","volume":"20","author":"GJ DuPaul","year":"1991","unstructured":"DuPaul, G. J. Parent and teacher ratings of adhd symptoms: psychometric properties in a community-based sample. J. Clin. Child Psychol. 20, 245\u2013253 (1991).","journal-title":"J. Clin. Child Psychol."},{"key":"3351_CR37","unstructured":"Constantino, J. The Social Responsiveness Scale., Western Psychological Service., (2002)."},{"key":"3351_CR38","unstructured":"Henning, A. in Encyclopedia of Spectroscopy and Spectrometry (Third Edition) (Lindon, J. C., Tranter, G. E. & Koppenaal, D. W. eds.) 192-198 (Academic Press, 2017)."},{"key":"3351_CR39","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1016\/j.neuroimage.2009.10.090","volume":"49","author":"J Chumbley","year":"2010","unstructured":"Chumbley, J., Worsley, K., Flandin, G. & Friston, K. Topological FDR for neuroimaging. Neuroimage 49, 3057\u20133064 (2010).","journal-title":"Neuroimage"},{"key":"3351_CR40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1515\/jtim-2016-0011","volume":"4","author":"D Lossignol","year":"2016","unstructured":"Lossignol, D. A little help from steroids in oncology. J. Transl. Int Med 4, 52\u201354 (2016).","journal-title":"J. Transl. Int Med"},{"key":"3351_CR41","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1113\/jphysiol.2005.084038","volume":"565","author":"C Forster","year":"2005","unstructured":"Forster, C. et al. Occludin as direct target for glucocorticoid-induced improvement of blood\u2013brain barrier properties in a murine in vitro system. J. Physiol. 565, 475\u2013486 (2005).","journal-title":"J. Physiol."},{"key":"3351_CR42","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/jcbfm.2015.38","volume":"35","author":"CD Hue","year":"2015","unstructured":"Hue, C. D. et al. Dexamethasone potentiates in vitro blood-brain barrier recovery after primary blast injury by glucocorticoid receptor-mediated upregulation of Zo-1 tight junction protein. J. Cereb. Blood Flow. Metab. 35, 1191\u20131198 (2015).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"3351_CR43","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0306-4530(90)90024-4","volume":"15","author":"OM Wolkowitz","year":"1990","unstructured":"Wolkowitz, O. M. et al. Prednisone effects on blood-brain barrier permeability and CNS IGG synthesis in healthy humans. Psychoneuroendocrinology 15, 155\u2013158 (1990).","journal-title":"Psychoneuroendocrinology"},{"key":"3351_CR44","doi-asserted-by":"publisher","first-page":"e41714","DOI":"10.7554\/eLife.41714","volume":"7","author":"NA Goriounova","year":"2018","unstructured":"Goriounova, N. A. et al. Large and fast human pyramidal neurons associate with intelligence. Elife 7, e41714 (2018).","journal-title":"Elife"},{"key":"3351_CR45","first-page":"295","volume":"5","author":"M Cay","year":"2018","unstructured":"Cay, M. et al. Effect of increase in cortisol level due to stress in healthy young individuals on dynamic and static balance scores. North Clin. Istanb. 5, 295\u2013301 (2018).","journal-title":"North Clin. Istanb."},{"key":"3351_CR46","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.3390\/ijms22052470","volume":"22","author":"S Trombetti","year":"2021","unstructured":"Trombetti, S. et al. Oxidative stress and ros-mediated signaling in leukemia: novel promising perspectives to eradicate chemoresistant cells in myeloid leukemia. Int J. Mol. Sci. 22, 2470 (2021).","journal-title":"Int J. Mol. Sci."},{"key":"3351_CR47","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bbacli.2015.01.006","volume":"3","author":"JA Hess","year":"2015","unstructured":"Hess, J. A. & Khasawneh, M. K. Cancer metabolism and oxidative stress: insights into carcinogenesis and chemotherapy via the non-dihydrofolate reductase effects of methotrexate. BBA Clin. 3, 152\u2013161 (2015).","journal-title":"BBA Clin."},{"key":"3351_CR48","first-page":"963","volume":"29","author":"EL Hobl","year":"2011","unstructured":"Hobl, E. L. et al. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine il-12a in the therapy of rheumatoid arthritis. Clin. Exp. Rheumatol. 29, 963\u2013969 (2011).","journal-title":"Clin. Exp. Rheumatol."},{"key":"3351_CR49","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1136\/ard.60.8.729","volume":"60","author":"M Cutolo","year":"2001","unstructured":"Cutolo, M., Sulli, A., Pizzorni, C., Seriolo, B. & Straub, R. H. Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. Ann. Rheum. Dis. 60, 729\u2013735 (2001).","journal-title":"Ann. Rheum. Dis."},{"key":"3351_CR50","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/1529-0131(199801)41:1<48::AID-ART7>3.0.CO;2-K","volume":"41","author":"A Constantin","year":"1998","unstructured":"Constantin, A. et al. Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction. Arthritis Rheum. 41, 48\u201357 (1998).","journal-title":"Arthritis Rheum."},{"key":"3351_CR51","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1046\/j.1365-2249.1999.00753.x","volume":"115","author":"MF Neurath","year":"1999","unstructured":"Neurath, M. F. et al. Methotrexate specifically modulates cytokine production by t cells and macrophages in murine collagen-induced arthritis (cia): a mechanism for methotrexate-mediated immunosuppression. Clin. Exp. Immunol. 115, 42\u201355 (1999).","journal-title":"Clin. Exp. Immunol."},{"key":"3351_CR52","doi-asserted-by":"publisher","first-page":"a025130","DOI":"10.1101\/cshperspect.a025130","volume":"5","author":"S Maynard","year":"2015","unstructured":"Maynard, S., Fang, E. F., Scheibye-Knudsen, M., Croteau, D. L. & Bohr, V. A. DNA damage, DNA repair, aging, and neurodegeneration. Cold Spring Harb. Perspect. Med 5, a025130 (2015).","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"3351_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/jbiol50","volume":"5","author":"J Dietrich","year":"2006","unstructured":"Dietrich, J., Han, R., Yang, Y., Mayer-Proschel, M. & Noble, M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J. Biol. 5, 22 (2006).","journal-title":"J. Biol."},{"key":"3351_CR54","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1093\/carcin\/bgaa114","volume":"41","author":"J Patel","year":"2020","unstructured":"Patel, J. et al. DNA damage and mitochondria in cancer and aging. Carcinogenesis 41, 1625\u20131634 (2020).","journal-title":"Carcinogenesis"},{"key":"3351_CR55","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1056\/NEJMra0804615","volume":"361","author":"JH Hoeijmakers","year":"2009","unstructured":"Hoeijmakers, J. H. DNA damage, aging, and cancer. N. Engl. J. Med 361, 1475\u20131485 (2009).","journal-title":"N. Engl. J. Med"},{"key":"3351_CR56","doi-asserted-by":"publisher","first-page":"e0151890","DOI":"10.1371\/journal.pone.0151890","volume":"11","author":"W Zhou","year":"2016","unstructured":"Zhou, W., Kavelaars, A. & Heijnen, C. J. Metformin prevents cisplatin-induced cognitive impairment and brain damage in mice. PLoS One 11, e0151890 (2016).","journal-title":"PLoS One"},{"key":"3351_CR57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/0006-8993(90)90892-F","volume":"516","author":"JB Gregorios","year":"1990","unstructured":"Gregorios, J. B. & Soucy, D. Effects of methotrexate on astrocytes in primary culture: light and electron microscopic studies. Brain Res. 516, 20\u201330 (1990).","journal-title":"Brain Res."},{"key":"3351_CR58","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.toxlet.2018.11.016","volume":"301","author":"Y Shao","year":"2019","unstructured":"Shao, Y., Tan, B., Shi, J. & Zhou, Q. Methotrexate induces astrocyte apoptosis by disrupting folate metabolism in the mouse juvenile central nervous system. Toxicol. Lett. 301, 146\u2013156 (2019).","journal-title":"Toxicol. Lett."},{"key":"3351_CR59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cell.2018.10.049","volume":"176","author":"EM Gibson","year":"2019","unstructured":"Gibson, E. M. et al. Methotrexate chemotherapy induces persistent tri-glial dysregulation that underlies chemotherapy-related cognitive impairment. Cell 176, 43\u201355.e13 (2019).","journal-title":"Cell"},{"key":"3351_CR60","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.3892\/or.2016.4657","volume":"35","author":"E Perez-Figueroa","year":"2016","unstructured":"Perez-Figueroa, E. et al. Strong inflammatory response and th1-polarization profile in children with acute lymphoblastic leukemia without apparent infection. Oncol. Rep. 35, 2699\u20132706 (2016).","journal-title":"Oncol. Rep."},{"key":"3351_CR61","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.it.2006.11.004","volume":"28","author":"I Galea","year":"2007","unstructured":"Galea, I., Bechmann, I. & Perry, V. H. What Is immune privilege (not)? Trends Immunol. 28, 12\u201318 (2007).","journal-title":"Trends Immunol."},{"key":"3351_CR62","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1038\/s41423-021-00757-x","volume":"18","author":"I Galea","year":"2021","unstructured":"Galea, I. The blood-brain barrier in systemic infection and inflammation. Cell Mol. Immunol. 18, 2489\u20132501 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"3351_CR63","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/(SICI)1096-9861(19981019)400:2<175::AID-CNE2>3.0.CO;2-6","volume":"400","author":"M Herkenham","year":"1998","unstructured":"Herkenham, M., Lee, H. Y. & Baker, R. A. Temporal and spatial patterns of C-Fos MRNA induced by intravenous interleukin-1: a cascade of non-neuronal cellular activation at the blood-brain barrier. J. Comp. Neurol. 400, 175\u2013196 (1998).","journal-title":"J. Comp. Neurol."},{"key":"3351_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0528-4","volume":"13","author":"TT Song","year":"2016","unstructured":"Song, T. T. et al. Systemic pro-inflammatory response facilitates the development of cerebral edema during short hypoxia. J. Neuroinflammation 13, 63 (2016).","journal-title":"J. Neuroinflammation"},{"key":"3351_CR65","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00134-011-2151-2","volume":"37","author":"CM Comim","year":"2011","unstructured":"Comim, C. M. et al. Traffic of leukocytes and cytokine up-regulation in the central nervous system in sepsis. Intensive Care Med 37, 711\u2013718 (2011).","journal-title":"Intensive Care Med"},{"key":"3351_CR66","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13195-015-0117-2","volume":"7","author":"C Cunningham","year":"2015","unstructured":"Cunningham, C. & Hennessy, E. Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research. Alzheimer\u2019s Res Ther. 7, 33 (2015).","journal-title":"Alzheimer\u2019s Res Ther."},{"key":"3351_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-4-4","volume":"4","author":"AW Lemstra","year":"2007","unstructured":"Lemstra, A. W. et al. Microglia activation in sepsis: a case-control study. J. Neuroinflammation 4, 4 (2007).","journal-title":"J. Neuroinflammation"},{"key":"3351_CR68","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.bbr.2009.10.009","volume":"207","author":"R Seigers","year":"2010","unstructured":"Seigers, R. et al. Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release. Behav. Brain Res. 207, 265\u2013272 (2010).","journal-title":"Behav. Brain Res."},{"key":"3351_CR69","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000112150","volume":"13","author":"JE Merrill","year":"1991","unstructured":"Merrill, J. E. Effects of interleukin-1 and tumor necrosis factor-alpha on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro. Dev. Neurosci. 13, 130\u2013137 (1991).","journal-title":"Dev. Neurosci."},{"key":"3351_CR70","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/ana.410230405","volume":"23","author":"KW Selmaj","year":"1988","unstructured":"Selmaj, K. W. & Raine, C. S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23, 339\u2013346 (1988).","journal-title":"Ann. Neurol."},{"key":"3351_CR71","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbi.2013.07.175","volume":"35","author":"TL Briones","year":"2014","unstructured":"Briones, T. L. & Woods, J. Dysregulation in myelination mediated by persistent neuroinflammation: possible mechanisms in chemotherapy-related cognitive impairment. Brain Behav. Immun. 35, 23\u201332 (2014).","journal-title":"Brain Behav. Immun."},{"key":"3351_CR72","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.neuropharm.2004.10.002","volume":"48","author":"M Banno","year":"2005","unstructured":"Banno, M. et al. The radical scavenger edaravone prevents oxidative neurotoxicity induced by peroxynitrite and activated microglia. Neuropharmacology 48, 283\u2013290 (2005).","journal-title":"Neuropharmacology"},{"key":"3351_CR73","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.4049\/jimmunol.151.4.2132","volume":"151","author":"JE Merrill","year":"1993","unstructured":"Merrill, J. E., Ignarro, L. J., Sherman, M. P., Melinek, J. & Lane, T. E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151, 2132\u20132141 (1993).","journal-title":"J. Immunol."},{"key":"3351_CR74","doi-asserted-by":"publisher","first-page":"11677","DOI":"10.3390\/ijms222111677","volume":"22","author":"GA Czapski","year":"2021","unstructured":"Czapski, G. A. & Strosznajder, J. B. Glutamate and gaba in microglia-neuron cross-talk in alzheimer\u2019s disease. Int J. Mol. Sci. 22, 11677 (2021).","journal-title":"Int J. Mol. Sci."},{"key":"3351_CR75","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0165-0173(94)00015-H","volume":"20","author":"J Gehrmann","year":"1995","unstructured":"Gehrmann, J., Matsumoto, Y. & Kreutzberg, G. W. Microglia: intrinsic immuneffector cell of the brain. Brain Res Brain Res Rev. 20, 269\u2013287 (1995).","journal-title":"Brain Res Brain Res Rev."},{"key":"3351_CR76","doi-asserted-by":"publisher","first-page":"e1545","DOI":"10.1002\/wsbm.1545","volume":"14","author":"BM Soteros","year":"2022","unstructured":"Soteros, B. M. & Sia, G. M. Complement and microglia dependent synapse elimination in brain development. WIREs Mech. Dis. 14, e1545 (2022).","journal-title":"WIREs Mech. Dis."},{"key":"3351_CR77","doi-asserted-by":"crossref","unstructured":"Parker, A., Yassin, A. & Woodman, K. Myelitis Following Intrathecal Chemotherapy in Acute Lymphoblastic Leukemia: A Case Report. Neurology 82 (2014).","DOI":"10.1212\/WNL.82.10_supplement.P3.307"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03351-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03351-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03351-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T12:43:55Z","timestamp":1738759435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03351-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3351"],"URL":"https:\/\/doi.org\/10.1038\/s41390-024-03351-9","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,1]]},"assertion":[{"value":"13 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors certify that they do not have any affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Study procedures were approved by the Institutional Review Board of Children\u2019s Hospital Los Angeles, CA, written informed consent was obtained from parents (or patients if age >18 years), and assent from youth <18 years.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent statement"}}]}}